SAN FRANCISCO -- For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, there was no clinical benefit to a strategy of finding and treating all nonculprit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback